ArticleRisk management and healthcare policy2025
Impact of DRG Reform Policies on Hospitalization Costs of Stroke Patients in Western China: Wisdom from Traditional Chinese Medicine.
Article in Risk management and healthcare policy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Economic toxicity and quality of life in stroke patients: a moderated mediation model of self-management and family function.Health and quality of life outcomes · 2026Article
- The effect of diagnosis-related group policy on treatment cost and treatment efficiency of inpatients with coronary heart disease in Xinjiang: an interrupted time series analysis.Journal of global health · 2026Article
- A study on the impact of DRG payment reform on hospitalization costs and outcomes of patients with fractures and intervertebral disc herniations.Frontiers in public health · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Stroke presents a significant economic burden worldwide, with the impact being especially pronounced in developing countries. China is currently implementing Diagnosis-Related Group (DRG) reforms, attempting to use more traditional Chinese medicine (TCM) modalities to alleviate the economic burden on stroke patients. Methods: This retrospective study extracted the medical records of stroke inpatients at Qingyang City Hospital of TCM from 2017 to 2022 from China's Gansu National Health Big Data Platform. A single-group interrupted time series (ITS) design was employed to assess the impact of DRG reform on patients' hospitalization costs and length of stay (LOS). Additionally, a two-group ITS was utilized to evaluate treatment costs and medicine costs. Results: The single-group ITS analysis indicated that the average LOS decreased by 0.06 days per month following the reform (P < 0.05), while the average hospitalization cost declined by 48.92 yuan per month (P < 0.05). The two-group ITS results revealed a significant reduction in the average monthly cost of Western medicine by 22.67 yuan post-reform (P < 0.05), whereas the average monthly cost of Chinese medicine increased by 2.93 yuan, though this change was not statistically significant (P > 0.05). Additionally, the average monthly cost of Western medical treatment decreased by 11.24 yuan (P < 0.05). Acupuncture and massage treatment costs exhibited an initial sharp increase followed by a downward trend, with an average monthly decrease of 9.53 yuan (P < 0.05). Conclusion: DRG reduced hospitalization costs and shortened the LOS of stroke patients, which may be related to the increased use of TCM in stroke treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.